Company

Recro Pharma, Inc.

Headquarters: Malvern, PA, United States

Employees: 213

CEO: Mr. J. David Enloe Jr.

NASDAQ: REPH -1.46%

Market Cap

$97.4 Million

USD as of June 1, 2022

Market Cap History

Recro Pharma, Inc. market capitalization over time

Evolution of Recro Pharma, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Recro Pharma, Inc.

Detailed Description

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Recro Pharma, Inc. has the following listings and related stock indices.


Stock: NASDAQ: REPH wb_incandescent

Stock: XSTU: RAH wb_incandescent

Details

Headquarters:

490 Lapp Road

Malvern, PA 19355

United States

Phone: 484 395 2470